Yiting Wang, PhD

Senior Director, RWE, Vertex Pharmaceuticals, Inc.

Global real-world evidence leader with over 20 years of experience shaping evidence strategies across multiple therapeutic areas, health care systems, and diverse data assets.

• Directs natural history studies to inform clinical trial design, endpoint selection, and regulatory submissions.
• Integrates evidence generation and scientific communications with regulatory requirements, professional guidelines, patient preferences, safety considerations, and payer value propositions to optimize portfolio life-cycle management.
• Supports pipeline development by evaluating epidemiologic evidence, competitive dynamics, and the data landscape to inform product acquisition decisions. 
• Spearheads practical application of novel study designs to accelerate approvals and market access while reducing costs.